The primary goal of the DRC Enrichment Program is to orchestrate a wide range of diabetes related activities within the Yale scientific community that promotes the open exchange of information and ideas among Yale DRC faculty, DRC trainees and students working in member labs as well as ?cutting edge? visiting scientists, thereby fostering interdisciplinary diabetes-related research collaborations and the training of the next generation of diabetes researchers. The Enrichment Program consists of 1) a weekly DRC-Endocrinology Seminar Series that is a collaboration of both the Sections of Adult and Pediatric Endocrinology and Metabolism; 2) diabetes- related Special Lectureships incorporated into the seminar programs or grand rounds of Internal Medicine, Comparative Medicine, Immunobiology, Cell Biology, OB-GYN and other basic science and clinical programs at Yale School of Medicine; 3) a yearly half-day DRC retreat to allow junior investigators to present their most recent research work, and 4) a Diabetes Research Day at the School of Medicine in which DRC supported scientists and a visiting scientist present their work. An important complementary aim of the program is through exposure to interdepartmental research activities and DRC cores to stimulate junior and senior faculty interest in diabetes- related scientific issues by investigators who are not currently engaged in the field. The explosion of knowledge in the basic biomedical sciences over the past two decades has created unparalleled opportunities for the advancement of diabetes treatment and prevention. To take maximal advantage of these opportunities, it is essential to attract the best and the brightest students, fellows, and junior faculty members to careers in diabetes research. The DRC has worked with major support from the CTSA-supported Yale Center for Clinical Investigation (YCCI) and T32 diabetes research training grants in medicine, pediatrics, and immunology, and other programs to accomplish this goal. In short, the mission of the DRC Enrichment Program is to create an educational infrastructure that will serve as a breeding ground for future academic leaders in diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK045735-29
Application #
10104509
Study Section
Special Emphasis Panel (ZDK1)
Project Start
1997-01-01
Project End
2023-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
29
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Vatner, Daniel F; Goedeke, Leigh; Camporez, Joao-Paulo G et al. (2018) Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents. Diabetologia 61:1435-1446
Keene, Danya E; Guo, Monica; Murillo, Sascha (2018) ""That wasn't really a place to worry about diabetes"": Housing access and diabetes self-management among low-income adults. Soc Sci Med 197:71-77
Hwang, Janice Jin; Parikh, Lisa; Lacadie, Cheryl et al. (2018) Hypoglycemia unawareness in type 1 diabetes suppresses brain responses to hypoglycemia. J Clin Invest 128:1485-1495
Wang, Yongliang; Nasiri, Ali R; Damsky, William E et al. (2018) Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer. Cell Rep 24:47-55
RISE Consortium (2018) Impact of Insulin and Metformin Versus Metformin Alone on ?-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes. Diabetes Care 41:1717-1725
Tan, Qiyuan; Tai, Ningwen; Li, Yangyang et al. (2018) Activation-induced cytidine deaminase deficiency accelerates autoimmune diabetes in NOD mice. JCI Insight 3:
Madiraju, Anila K; Qiu, Yang; Perry, Rachel J et al. (2018) Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat Med 24:1384-1394
Goldberg, Ira J; Reue, Karen; Abumrad, Nada A et al. (2018) Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop. Circulation 138:305-315
Stamatouli, Angeliki M; Quandt, Zoe; Perdigoto, Ana Luisa et al. (2018) Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors. Diabetes 67:1471-1480
Li, Nina Xiaoyan; Brown, Stacey; Kowalski, Tim et al. (2018) GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia. Diabetes 67:1401-1413

Showing the most recent 10 out of 620 publications